Centre for Evidence Based Drug Policy

The Centre for Evidence Based Drug Policy is a UK-based evidence and policy forum that promotes informed debate on drug policy reform. It describes itself as non-governmental, politically unaffiliated, and working on a cross-party basis to influence Parliamentarians and other decision makers. Its stated focus includes drug policy governance, medical psychedelics, and cannabis and CBD, with an emphasis on reducing harm, improving public health, and unlocking medical and economic benefits.

The organization plays a drug policy reform and public policy role rather than a direct patient-service role. It explicitly campaigns for evidence-based reform across areas such as cannabis and psychedelics-based medicines, heroin-assisted treatment, and naloxone access, and it has a visible medical psychedelics workstream centered on psilocybin rescheduling and patient access. Documented current activities include a CBD regulatory campaign, a request for clarification on the UK Food Standards Agency's CBD acceptable daily intake update, and policy briefings to government, opposition, and international decision makers.